| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
68,224 |
62,809 |
$2.37M |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
19,356 |
18,954 |
$1.52M |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
20,155 |
19,628 |
$1.00M |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
19,416 |
19,053 |
$565K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
5,952 |
5,909 |
$485K |
| 87634 |
|
8,332 |
8,188 |
$484K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
5,529 |
5,413 |
$480K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
8,968 |
8,474 |
$437K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
14,591 |
14,073 |
$348K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
4,459 |
4,408 |
$346K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
30,003 |
28,666 |
$182K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,048 |
1,989 |
$154K |
| 99000 |
|
14,513 |
13,825 |
$147K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
12,832 |
12,582 |
$137K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
13,741 |
6,631 |
$122K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
6,459 |
5,523 |
$75K |
| 99050 |
|
5,024 |
4,867 |
$74K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,309 |
1,282 |
$74K |
| 80053 |
Comprehensive metabolic panel |
8,674 |
8,441 |
$63K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
784 |
770 |
$61K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,383 |
1,673 |
$46K |
| 80061 |
Lipid panel |
4,499 |
4,380 |
$44K |
| 71046 |
Radiologic examination, chest; 2 views |
1,811 |
1,773 |
$44K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,153 |
1,137 |
$42K |
| 80050 |
General health panel |
897 |
877 |
$27K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
3,181 |
3,159 |
$26K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,789 |
1,763 |
$24K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,686 |
1,656 |
$22K |
| 81003 |
|
11,178 |
10,442 |
$19K |
| 92567 |
|
1,288 |
1,248 |
$15K |
| 82947 |
|
6,943 |
6,374 |
$13K |
| 82044 |
|
3,310 |
3,237 |
$13K |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
1,000 |
963 |
$12K |
| 90473 |
|
1,124 |
1,113 |
$12K |
| 96160 |
|
5,431 |
5,258 |
$10K |
| 93000 |
|
952 |
919 |
$9K |
| 94060 |
|
251 |
248 |
$9K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
202 |
200 |
$8K |
| 83655 |
|
812 |
803 |
$8K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
1,647 |
1,541 |
$8K |
| 99091 |
|
44 |
44 |
$7K |
| 84443 |
Thyroid stimulating hormone (TSH) |
578 |
556 |
$6K |
| 87807 |
|
535 |
530 |
$6K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
101 |
96 |
$6K |
| 83013 |
|
73 |
71 |
$4K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,853 |
1,737 |
$4K |
| 90686 |
|
5,353 |
5,199 |
$3K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
349 |
338 |
$3K |
| 74019 |
|
96 |
92 |
$3K |
| 0012A |
|
91 |
91 |
$3K |
| 0011A |
|
90 |
89 |
$3K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
38 |
37 |
$3K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
47 |
41 |
$3K |
| 90674 |
|
118 |
115 |
$2K |
| 84481 |
|
173 |
166 |
$2K |
| 84439 |
|
315 |
303 |
$2K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
28 |
24 |
$2K |
| 86703 |
|
172 |
166 |
$2K |
| 99460 |
|
24 |
24 |
$2K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
15 |
13 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
267 |
263 |
$2K |
| 90688 |
|
115 |
103 |
$1K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,012 |
951 |
$1K |
| 90656 |
|
887 |
885 |
$1K |
| 99490 |
Ccm add 20min |
1,311 |
1,304 |
$1K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
12 |
12 |
$983.19 |
| 90670 |
|
1,667 |
1,650 |
$936.28 |
| 99462 |
|
24 |
12 |
$874.92 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
32 |
31 |
$683.63 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
32 |
31 |
$683.63 |
| 81025 |
|
76 |
74 |
$535.39 |
| 92250 |
|
15 |
15 |
$527.68 |
| 3044F |
|
2,254 |
2,019 |
$480.00 |
| 83014 |
|
73 |
71 |
$437.90 |
| 84153 |
|
26 |
26 |
$425.37 |
| 82728 |
|
37 |
37 |
$423.65 |
| 0013A |
|
27 |
27 |
$363.20 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
15 |
14 |
$314.89 |
| 99429 |
|
12 |
12 |
$283.54 |
| 90651 |
|
1,403 |
1,354 |
$272.56 |
| 94760 |
|
148 |
145 |
$262.60 |
| 3046F |
|
787 |
650 |
$220.00 |
| 90715 |
|
552 |
543 |
$219.51 |
| 92285 |
|
15 |
15 |
$162.49 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
14 |
13 |
$157.42 |
| 90734 |
|
1,706 |
1,656 |
$155.35 |
| 99439 |
|
302 |
302 |
$142.08 |
| 3051F |
|
200 |
173 |
$140.00 |
| 87481 |
|
14 |
13 |
$127.94 |
| 86308 |
|
28 |
28 |
$121.80 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
2,679 |
2,609 |
$117.28 |
| 82274 |
|
12 |
12 |
$98.13 |
| 86580 |
|
14 |
14 |
$90.44 |
| 84479 |
|
170 |
164 |
$70.85 |
| 84436 |
|
172 |
165 |
$57.96 |
| 84550 |
|
16 |
16 |
$53.52 |
| 82950 |
|
12 |
12 |
$47.88 |
| 99487 |
Ccm add 20min |
82 |
82 |
$44.90 |
| 88142 |
|
213 |
208 |
$34.04 |
| 36415 |
Collection of venous blood by venipuncture |
1,163 |
1,095 |
$5.25 |
| 90677 |
|
569 |
554 |
$3.25 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
12 |
12 |
$2.06 |
| 90680 |
|
1,136 |
1,109 |
$0.10 |
| 90723 |
|
502 |
500 |
$0.09 |
| 90648 |
|
956 |
949 |
$0.08 |
| 90633 |
|
1,408 |
1,386 |
$0.03 |
| 90707 |
|
282 |
277 |
$0.02 |
| 90716 |
|
293 |
290 |
$0.02 |
| 3354F |
|
16 |
14 |
$0.02 |
| 3353F |
|
61 |
57 |
$0.02 |
| 99177 |
|
1,081 |
1,024 |
$0.01 |
| 90713 |
|
12 |
12 |
$0.01 |
| 3079F |
|
3,669 |
3,386 |
$0.01 |
| 3078F |
|
4,592 |
4,206 |
$0.00 |
| 1159F |
|
11,157 |
9,738 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
1,443 |
1,273 |
$0.00 |
| 1160F |
|
11,158 |
9,737 |
$0.00 |
| 90700 |
|
340 |
333 |
$0.00 |
| 3077F |
|
746 |
688 |
$0.00 |
| 0502F |
|
1,575 |
1,019 |
$0.00 |
| 2028F |
|
304 |
287 |
$0.00 |
| 90710 |
|
413 |
409 |
$0.00 |
| 1090F |
|
49 |
46 |
$0.00 |
| 3050F |
|
92 |
85 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
482 |
425 |
$0.00 |
| 3288F |
|
55 |
52 |
$0.00 |
| G8476 |
Most recent blood pressure has a systolic measurement of < 140 mmhg and a diastolic measurement of < 90 mmhg |
39 |
38 |
$0.00 |
| 99497 |
|
18 |
13 |
$0.00 |
| 1125F |
|
3,500 |
3,201 |
$0.00 |
| 1034F |
|
433 |
404 |
$0.00 |
| 1126F |
|
1,132 |
1,059 |
$0.00 |
| 3008F |
|
6,121 |
5,725 |
$0.00 |
| 3074F |
|
6,332 |
5,696 |
$0.00 |
| 3060F |
|
910 |
889 |
$0.00 |
| 3075F |
|
1,071 |
1,017 |
$0.00 |
| 90620 |
|
130 |
130 |
$0.00 |
| 1000F |
|
429 |
401 |
$0.00 |
| 90697 |
|
278 |
272 |
$0.00 |
| 1036F |
|
52 |
44 |
$0.00 |
| 90698 |
|
72 |
69 |
$0.00 |
| 1220F |
|
946 |
921 |
$0.00 |
| 90696 |
|
400 |
397 |
$0.00 |
| 91301 |
|
174 |
169 |
$0.00 |
| 3049F |
|
41 |
37 |
$0.00 |
| 0501F |
|
171 |
160 |
$0.00 |
| 3048F |
|
221 |
209 |
$0.00 |
| 0503F |
|
59 |
55 |
$0.00 |
| 3080F |
|
214 |
201 |
$0.00 |
| 3061F |
|
747 |
734 |
$0.00 |
| 3351F |
|
26 |
26 |
$0.00 |
| 1170F |
|
54 |
48 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
34 |
25 |
$0.00 |
| 99459 |
|
15 |
15 |
$0.00 |